Author's posts
A tale of 2 COVID-19 trials: compassionate use vs. EUA
We all need hope this holiday season, but as an experienced physician, biostatistician, and research methodologist, it is my duty to share why the encouraging vaccine results reported by pharma companies in the last month must be applauded but interpre…
